Patients who have a family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome Type 2 are not ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

The Maryland program’s spending on both obesity drugs grew 86% year-over-year, Real Chemistry said, the seventh highest in ...

Around the holidays – when many people are baking cookies for Santa, enjoying cocktail parties or having festive family feasts – some adults who use popular medications for diabetes or weight loss ...

Dizziness can occur in relation to type 2 diabetes due to low or high blood sugar, diabetes medications, or dehydration. A doctor can help determine the cause and how to manage or treat it.

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...